Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole + Lamotrigine in Bipolar I Disorder
NCT00277212Phase 4Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Dec 2005
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 4, randomised, double-blind trial in bipolar I disorder comparing Lamotrigine + Aripiprazole with Lamotrigine + Placebo (2 arms). Primary endpoint: Proportion of Participants Not Experiencing Relapse at 52 weeks. Started Dec 2005; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT00277212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277212.